Earnings History Data for Gritstone bio (GRTS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Gritstone bio
Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types. The company has built its tumor-specific immunotherapy approach on two key pillars - first, a proprietary machine learning-based platform, Gritstone EDGE(TM), which provides a powerful ability to predict from a routine tumor biopsy the tumor-specific neoantigens, or TSNA, that are presented on a patient?s tumor cells; and second, the ability to develop and manufacture potent immunotherapies utilizing patients? TSNA to drive the patient?s immune system to attack and destroy tumors.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05-03-2024 | AH | GRTS | Gritstone bio | 193.00 | -0.26 | -0.36 | 0.00 | Gritstone bio GAAP EPS of -$1.20 beats by $0.12, revenue of $16.34M beats by $5.77M [3/5/2024 4:32 PM] |
2.18 | 0.14 (6.86%) |
2.15 | 0.11 (5.39%) |
1.14 - 3.33 | 1,277,350 | 2,120,000 | 8,583 | ||
| 08-11-2023 | AH | GRTS | Gritstone bio | 170.00 | -0.33 | -0.35 | 0.00 | Gritstone bio GAAP EPS of -$0.33 beats by $0.03, revenue of $1.57M misses by $0.64M [11/8/2023 5:14 PM] |
1.56 | -0.12 (-7.40%) |
1.75 | 0.06 (3.53%) |
1.14 - 4.05 | 739,864 | 820,000 | 2,638 | ||
| 09-08-2023 | AH | GRTS | Gritstone bio | 151.00 | -0.31 | -0.34 | 0.00 | Gritstone bio GAAP EPS of -$0.31 beats by $0.05, revenue of $1.96M misses by $0.51M [8/9/2023 5:32 PM] |
1.82 | 0.07 (3.88%) |
1.83 | 0.08 (4.57%) |
1.64 - 5.85 | 569,263 | 460,000 | 2,338 | ||
| 11-05-2023 | AH | 4:05 PM ET (May 11) |
GRTS | Gritstone bio, Inc. | 226.17 | -0.30 | -0.32 | -0.34 | Gritstone bio GAAP EPS of -$0.30 beats by $0.04, revenue of $2.44M misses by $0.73M [5/11/2023 4:08 PM] |
2.36 | -0.25 (-9.58%) |
2.65 | 0.0 (0.00%) |
1.71 - 5.85 | 699,020 | 390,000 | 1,520 | |
| 09-03-2023 | AH | 4:05 PM ET (Mar 9) |
GRTS | Gritstone bio, Inc. | 210.08 | -0.30 | -0.34 | -0.36 | Gritstone Oncology GAAP EPS of -$1.32 beats by $0.10, revenue of $19.95M beats by $1.36M [3/9/2023 4:31 PM] |
2.17 | -0.14 (-6.17%) |
2.20 | -0.11 (-4.76%) |
1.71 - 5.85 | 1,597,290 | 530,000 | 118,845 | |
| 04-08-2022 | AH | 4:05 PM ET (Aug 4) |
GRTS | Gritstone bio, Inc. | 198.05 | -0.34 | -0.40 | -0.33 | Gritstone Oncology GAAP EPS of -$0.34 beats by $0.07, revenue of $5.47M beats by $2.28M [8/4/2022 5:39 PM] |
3.43 | 0.03 (0.88%) |
3.43 | 0.0 (0.00%) |
1.71 - 14.42 | 1,072,044 | 540,000 | 2,094 | |
| 05-05-2022 | AH | 4:05 PM ET (May 5) |
GRTS | Gritstone bio, Inc. | 199.22 | -0.34 | -0.33 | 0.10 | Gritstone Oncology GAAP EPS of -$0.34 beats by $0.02, revenue of $7.19M beats by $2.98M [5/5/2022 5:32 PM] |
2.38 | -0.19 (-7.56%) |
2.65 | 0.07 (2.71%) |
2.33 - 14.42 | 1,125,853 | 1,150,000 | 1,217 | |
|
||||||||||||||||||
| 03-11-2021 | AH | GRTS | Gritstone bio | 575.00 | -0.36 | -0.44 | 0.00 | Gritstone Oncology EPS beats by $0.11, beats on revenue [11/3/2021 5:30 PM] |
11.22 | 0.03 (0.27%) |
9.98 | -1.21 (-10.81%) |
2.54 - 35.20 | 1,438,615 | 870,000 | 21,043 | ||
| 05-08-2021 | AH | GRTS | Gritstone bio, Inc. | 339.96 | -0.33 | -0.52 | -0.69 | Gritstone Oncology EPS beats by $0.23, beats on revenue [8/5/2021 4:58 PM] |
6.90 | -0.05 (-0.72%) |
6.87 | -0.08 (-1.15%) |
2.54 - 35.20 | 470,016 | 830,000 | 2,043 | ||
| 06-05-2021 | PM | GRTS | Gritstone Oncology, Inc. | 429.50 | 0.10 | -0.46 | -0.71 | Gritstone Oncology EPS beats by $0.41, beats on revenue [5/6/2021 9:23 AM] |
8.13 | -0.37 (-4.35%) |
8.90 | 0.40 (4.71%) |
2.54 - 35.20 | 728,879 | 390,000 | 11,594 | ||
| 11-03-2021 | PM | GRTS | Gritstone Oncology, Inc. | 676.76 | -0.69 | -0.69 | -0.77 | Gritstone Oncology EPS misses by $0.05, beats on revenue [3/11/2021 9:38 AM] |
15.72 | 0.98 (6.65%) |
14.74 | 0.0 (0.00%) |
2.54 - 35.20 | 726,211 | 549,786 | 374 | ||